The Masonic Cancer Center, University of Minnesota brings together more than 500 U faculty and researchers from dozens of fields who are conquering cancer from many angles. Recent Masonic support has fueled pioneering research on some of the most promising cancer therapies in the field, accelerating a shift from conventional therapies to more targeted and personalized approaches.
Featured stories
 One of the biggest obstacles to creating new cancer therapies is the time it takes to move them from lab to person. |
 In addition to causing side effects such as vomiting or hair loss, chemotherapy is thought to play a significant role in how patients respond to... Read more |
 With a five-year survival rate of 27 percent, acute myeloid leukemia (AML), which starts in bone marrow and quickly moves into blood, is one of the... Read more |
 Improved screening, earlier diagnosis, and new treatments have increased the prognosis for many, but some develop advanced prostate cancer that no... Read more |
 While acute myeloid leukemia (AML) is one of the most common types of leukemia in adults, there is currently not a cure. That’s why researchers at... Read more |
 An exciting evolution in cancer research has been the development of epigenetic therapies, which reprogram cancer cells to adopt a healthier state. |
 In patients with acute myeloid leukemia (AML) undergoing intense chemotherapy, as well as those undergoing stem cell transplantation, bloodstream... Read more |
 Caring for cancer patients inspired Manish Patel, D.O., to become a researcher. |
 As a child, Brian Betts, M.D., benefitted firsthand from the exceptional health care provided at the University of Minnesota and Children’s Hospital... Read more |
 Beau Webber, Ph.D., part of the U’s pediatrics faculty, marvels that our own immune cells can be reprogrammed to fight advanced cancers. That... Read more |
 As a predoctoral fellow at the National Institutes of Health, Ingunn Stromnes, Ph.D., became captivated by how the immune system is essential for... Read more |
 With Masonic support, David Potter, M.D., Ph.D., a hematology, oncology, and transplantation faculty member, is working to improve outcomes for women... Read more |
 Cancer is a genetic disease, occurring when inherited or environmental factors corrupt the DNA in cells.
Although scientists have made strides in... Read more |